BaxHTN phase 3 trial: Aldosterone dysregulation is considered a key driver of hard-to-control hypertension. Research findings on baxdrostat, a highly selective, potent aldosterone synthase inhibitor, in hard-to-control hypertension are summarized in a new Quick Take video. nej.md/3KCsQGJ

Following the ESE Executive Committee meeting in Munich last week, members of the ESE leadership team were delighted to be invited to the retirement lecture for Martin Reincke, Past-President of ESE, at @lmumuenchen.bsky.social. We wish Martin all the best in his next chapter. #OurEndocrineCommunity

New in the October 9, 2025, issue of NEJM: Baxdrostat Efficacy and Safety in Uncontrolled Hypertension (BaxHTN phase 3 trial) nej.md/4my7xUZ Nexiguran Ziclumeran in ATTR with Polyneuropathy nej.md/46Qhur7 #MedSky

Endocrine Feedback Loop | Listen to Oksana Hamidi, DO, MSCS, and Jill Wagoner, MD, discuss a recent #JCEM article (http://bit.ly/4pC3BEl)on mild autonomous cortisol secretion (MACS) is associated with increased risk of vertebral fractures (VFx) (https://bit.ly/EFL065)

Got to Baltimore #Hypertension25 so excited to see friends and colleagues talking about high BP ! @ahascience.bsky.social @giaconajohn.bsky.social

A global real-world study assessing total time to adrenalectomy in primary aldosteronism by Charmaine Ter et al EJE Volume 193, Issue 1, July 2025 Open access article 👉 doi.org/10.1093/ejen... #endocrinology #adrenalectomy #aldosteronism

Watch our videos with Annual Meeting Steering Committee Chair (AMSC) Gisella Carranza Leon, MD, on creation of ENDO programming and how submitting a session idea can help you in your career. She provides insight in English (bit.ly/3UOXNJB) and Español (bit.ly/47RuYUz). #ENDO2026 #endocrinology

#ENDO2026 Welcomes Your Ideas | Our annual meeting will take place in Chicago, IL, June 13–16, and I’m inviting YOU to shape the program💡Submit your symposium proposal or session suggestion by Tuesday, September 2: bit.ly/4flCMjl #endocrinology @TheEndoSociety

Join us @jordybc.bsky.social , Keith Ferdinand, and Dan Jones unpacking 2025 AHA/ACC guidelines on Thursday Aug 28 bit.ly/Guideline25W... @UTSWInternalMed @utswheart

“Diabetes and Pregnancy” has been long anticipated. For the first time, clinicians will have a definitive guide on treating these patients that now includes the most recent technological breakthroughs in diabetes treatments. Read more in @endocrinenews.bsky.social: bit.ly/45FR4rx #endocrinology

Shalender Bhasin, MB, BS, and Peter J. Snyder, MD, review available data on the benefits and risks of testosterone treatment in middle-aged and older men with moderate hypogonadism. Learn more in a new Review Article: nej.md/4ooeFo7 #MedSky #EndoSky #Urology

New Primary Aldosteronism Guidelines - simpler, streamlined, and hopefully more pragmatic academic.oup.com/jcem/advance...

A5 meeting under way in San Francisco, led by our executive chair Dr Habra. #adrenal

@lmfendo.bsky.social at @endocrinesociety.bsky.social #ENDO2025 presents new data on modifier genes in paraganglioma-pheochromocytoma from GWAS studies with close to 2000 tumor samples from @a5-adrenal.bsky.social teams around the globe. New targets, new biology. Hope for new therapies!

Editor-in-Chief @zane-andrews.bsky.social will be chairing our #Endocrinology Journal Symposium at 8:00 AM in Room 308 to examine GLP-1-based therapies and the emergence of GLP-1-based multi-agonists combining with other hormones: bit.ly/4lMdrku #ENDO2025 @endosocjournals.bsky.social

New PA Endo guideline is also out by experts @anandvaidya17.bsky.social #Cardiosky @hswapnil.medsky.social doi.org/10.1210/clin...

Get ready for the third day of ENDO | It was great seeing everyone yesterday for a day full of science! We cannot wait to host you tomorrow. Join us for a wide range of networking events. View our program planner and mark your schedule: bit.ly/4nJotbW

A medical adrenalectomy? ASIs advance - Baxdrostat in primary aldosteronism now www.nejm.org/doi/full/10.... n = 15 single arm trial from @adinaturcu.bsky.social and @astra-zeneca.bsky.social in @nejm.org ~ 25/10 mm Hg BP lowering and impressive aldosterone level drop #Hypertension #EndoSky

Congratulations @adinaturcu.bsky.social & co-authors 👏👏 Exciting time for 🔦 on the equally important second “A” in #RAAS 😁

Outstanding talk here at @endocrineoncology.bsky.social #ENDO2025 on adrenal Cushing genomics by University of Michigan adrenal team member Juilee Rege here at #ENDO2025. Go Juilee, Go Blue, Go @A5-Alliance

In 15 patients with primary aldosteronism, baxdrostat (a second-generation, nonimidazole aldosterone synthase inhibitor) resolved or reduced the severity of hypertension, excessive aldosterone production, and hypokalemia. Full SPARK study results: nej.md/40Js1kz #ENDO2025

Join us! ESE Talks...Rare Diseases - CAH; diagnostic and therapeutic challenges across the entire lifespan - A joint webinar with ESE, Endo-ERN and ESPE. 📅 2 September, 17:00-18:30 CEST Register for free 👉 ow.ly/I29350W2XNp #RareDiseases #CAH #Endocrinology

Accurate steroid replacement is essential for children with adrenal insufficiency, but giving medication to kids can be a game of cat and mouse. Hydrocortisone granules are a game changer. Read more: NADF.us/children-with-adrenal-insufficiency #AADAM2025 #AdrenalDiseaseAwareness #AdrenalDisease

Register today for the Adrenal Disease Awareness Month Webinar with #AAES and #NADFAdrenal. We are excited to bring you this annual event as part of #AADAM2025. April 10, 2025 - 8pm EST / 5pm PST Visit bit.ly/AAES-NADF to register

Thanks to @UshmaNeill for running the Conversation of Giants in Medicine series for over a decade. Since its inception in 2012, this series has spanned 74 interviews with 80 pioneer scientists: jci.org/videos/cgms Last but not least episode: Video: buff.ly/LF6DMYz Article: jci.org/articles/vie...

Interesting news recycling. Looking forward to this year’s presentation from Ashley Grossman www.ese-hormones.org/what-we-do/a...

Opioids and the Endocrine System | Listen to Niki Karavitaki, PhD discuss use and misuse of opioids and recent research on the endocrine-related implications in this @endocrinenews.bsky.social Podcast episode: bit.ly/3RjqVa6 #opioids #EndoSky

Endocrine Self-Assessment Program (ESAP) 2025 Is Now Available | Order our dynamic self-study tool is designed to boost your expertise and elevate the quality of care you provide to your patients. Claim up to 40 AMA PRA Category 1 Credits: bit.ly/4i1C8rJ #endocrinology #EndoSky

The Primary Aldosteronism Medical Treatment Outcome (#PAMO) criteria represent an internationally developed outcome standard that can guide clinical practice and research into #primary #aldosteronism www.thelancet.com/journals/lan... #FREE to read with registration (also FREE) #MedSky #EndoSky

Delighted to share perspective piece @CircAHA on history of resistant HTN with @adinaturcu.bsky.social. In the US, it was 1st defined by JNC V report. Back then, RH need combination of diuretic+2 drugs: BB, vasodilator, CCB, or ACEI. We have come a long way! #Cardiosky #Nephsky tinyurl.com/3tttvaye

Endocrine Feedback Loop Podcast | Listen to @andrewkraftson.bsky.social, and Beverly Tchang, MD, discuss the JCEM article, “Defining Overweight and Obesity by Percent Body Fat Instead of Body Mass Index” (bit.ly/4k7sMMC) in this episode (bit.ly/EFL058) #JCEM #endocrinology #obesity #EndoSky

Endocrine Feedback Loop Podcast | Listen to Andrew Kraftson, MD, and Beverly Tchang, MD, discuss the JCEM article, “Defining Overweight and Obesity by Percent Body Fat Instead of Body Mass Index” (bit.ly/4k7sMMC) in this episode (bit.ly/EFL058) #JCEM #EndoSky #Obesity